Literature DB >> 9223519

Probing the substrate specificity of hepatitis C virus NS3 serine protease by using synthetic peptides.

R Zhang1, J Durkin, W T Windsor, C McNemar, L Ramanathan, H V Le.   

Abstract

We probed the substrate specificity of a recombinant noncovalent complex of the full-length hepatitis C virus (HCV) NS3 serine protease and NS4A cofactor, using a series of small synthetic peptides derived from the three trans-cleavage sites of the HCV nonstructural protein sequence. We observed a distinct cleavage site preference exhibited by the enzyme complex. The values of the turnover number (k(cat)) for the most efficient NS4A/4B, 4B/5A, and 5A/5B peptide substrates were 1.6, 11, and 8 min(-1), respectively, and the values for the corresponding Michaelis-Menten constants (Km) were 280, 160, and 16 microM, providing catalytic efficiency values (k(cat)/Km) of 92, 1,130, and 8,300 M(-1) s(-1). An alanine-scanning study for an NS5A/5B substrate (P6P4') revealed that P1 Cys and P3 Val were critical. Finally, substitutions at the scissile P1 Cys residue by homocysteine (Hcy), S-methylcysteine (Mcy), Ala, S-ethylcysteine (Ecy), Thr, Met, D-Cys, Ser, and penicillamine (Pen) produced progressively less efficient substrates, revealing a stringent stereochemical requirement for a Cys residue at this position.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223519      PMCID: PMC191885     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase.

Authors:  R Bartenschlager; L Ahlborn-Laake; K Yasargil; J Mous; H Jacobsen
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

2.  Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide.

Authors:  J L Kim; K A Morgenstern; C Lin; T Fox; M D Dwyer; J A Landro; S P Chambers; W Markland; C A Lepre; E T O'Malley; S L Harbeson; C M Rice; M A Murcko; P R Caron; J A Thomson
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

3.  Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation.

Authors:  R Bartenschlager; V Lohmann; T Wilkinson; J O Koch
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

4.  Kinetic and structural analyses of hepatitis C virus polyprotein processing.

Authors:  R Bartenschlager; L Ahlborn-Laake; J Mous; H Jacobsen
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

5.  Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins.

Authors:  C Failla; L Tomei; R De Francesco
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Structure and organization of the hepatitis C virus genome isolated from human carriers.

Authors:  A Takamizawa; C Mori; I Fuke; S Manabe; S Murakami; J Fujita; E Onishi; T Andoh; I Yoshida; H Okayama
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

Authors:  M J Alter; H S Margolis; K Krawczynski; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; M A Gerber; R E Sampliner
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

8.  Enzymatic characterization of purified NS3 serine proteinase of hepatitis C virus expressed in Escherichia coli.

Authors:  A Mori; K Yamada; J Kimura; T Koide; S Yuasa; E Yamada; T Miyamura
Journal:  FEBS Lett       Date:  1996-01-02       Impact factor: 4.124

9.  Activity of purified hepatitis C virus protease NS3 on peptide substrates.

Authors:  C Steinkühler; A Urbani; L Tomei; G Biasiol; M Sardana; E Bianchi; A Pessi; R De Francesco
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  Expression and identification of hepatitis C virus polyprotein cleavage products.

Authors:  A Grakoui; C Wychowski; C Lin; S M Feinstone; C M Rice
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more
  17 in total

1.  The effect of prime-site occupancy on the hepatitis C virus NS3 protease structure.

Authors:  Annarita Casbarra; Fabrizio Dal Piaz; Paolo Ingallinella; Stefania Orrù; Piero Pucci; Antonello Pessi; Elisabetta Bianchi
Journal:  Protein Sci       Date:  2002-09       Impact factor: 6.725

Review 2.  Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target.

Authors:  Kevin D Raney; Suresh D Sharma; Ibrahim M Moustafa; Craig E Cameron
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

3.  A drug-controllable tag for visualizing newly synthesized proteins in cells and whole animals.

Authors:  Michael Z Lin; Jeffrey S Glenn; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-29       Impact factor: 11.205

Review 4.  Protease inhibitors as antiviral agents.

Authors:  A K Patick; K E Potts
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

5.  In vivo selection of protease cleavage sites by using chimeric Sindbis virus libraries.

Authors:  L Pacini; A Vitelli; G Filocamo; L Bartholomew; M Brunetti; A Tramontano; C Steinkühler; G Migliaccio
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Hepatitis G virus encodes protease activities which can effect processing of the virus putative nonstructural proteins.

Authors:  A S Belyaev; S Chong; A Novikov; A Kongpachith; F R Masiarz; M Lim; J P Kim
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Construction, expression, and characterization of a novel fully activated recombinant single-chain hepatitis C virus protease.

Authors:  S S Taremi; B Beyer; M Maher; N Yao; W Prosise; P C Weber; B A Malcolm
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

8.  Elucidating novel hepatitis C virus-host interactions using combined mass spectrometry and functional genomics approaches.

Authors:  Marie-Anne Germain; Laurent Chatel-Chaix; Bridget Gagné; Éric Bonneil; Pierre Thibault; Fabrine Pradezynski; Benoît de Chassey; Laurène Meyniel-Schicklin; Vincent Lotteau; Martin Baril; Daniel Lamarre
Journal:  Mol Cell Proteomics       Date:  2013-10-29       Impact factor: 5.911

9.  Conserved C-terminal threonine of hepatitis C virus NS3 regulates autoproteolysis and prevents product inhibition.

Authors:  Wenyan Wang; Frederick C Lahser; MinKyung Yi; Jacquelyn Wright-Minogue; Ellen Xia; Patricia C Weber; Stanley M Lemon; Bruce A Malcolm
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  How to find simple and accurate rules for viral protease cleavage specificities.

Authors:  Thorsteinn Rögnvaldsson; Terence A Etchells; Liwen You; Daniel Garwicz; Ian Jarman; Paulo J G Lisboa
Journal:  BMC Bioinformatics       Date:  2009-05-16       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.